Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women
Condition(s) studied
Investigational drug(s) / intervention(s)
Hypnobreastfeeding Education: Monitoring anxiety and breastfeeding intention in pregnancy, and assessing perception of insufficient milk supply, and breastfeeding adaptation in postpartum period
Study summary
It is thought that hypnobreastfeeding training given to high-risk pregnant women will reduce anxiety levels, increase lactation, encourage breastfeeding, reduce the perception of insufficient milk, and facilitate adaptation to the postpartum breastfeeding process. According to the results of the power analysis, at least 68 high-risk pregnant women, 34 experimental and 34 control, should be included in the study. Data will be collected with the "Pregnancy Information Form", "Anxiety Assessment Scale", " Infant Feeding Intention Instrument", "Postpartum Information Form", "Perception of Insufficient Milk Questionnaire" and "Breastfeeding Adaptation Scale". In the research, hypnobreastfeeding training will be applied by the researcher to the high-risk pregnant women in the experimental group.
Eligibility
Primary outcome measure(s)
- Anxiety Assessment Scale — At the end of the 1 months
The minimum score that can be obtained from the scale is "10", the maximum score is "50", and as the score obtained from the scale increases, anxiety levels also increase. - Infant Feeding Intention Instrument — At the end of the 1 months
The minimum score that can be obtained from the scale is "0", the maximum score is "16", and as the score obtained from the scale increases, intention to exclusively breastfeed the baby levels also increase.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Amasya University | Amasya | Turkey (Türkiye) | Recruiting |
More Amasya University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07281339 on ClinicalTrials.gov ↗ ← All trials in Turkey